Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-30 @ 9:15 PM
Study NCT ID:
NCT03869632
Status:
UNKNOWN
Last Update Posted:
2021-11-16
First Post:
2019-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YL-13027-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None